ANR2022 will be structured in seven main topics with a special focus on immuno-therapy and relapse development through genetic and non-genetic mechanisms. Prof. Chris Marine (KUL, Leuven, Belgium) will give an invited lecture on his ground-breaking research in the role of plasticity and mutations in melanoma relapses. Immune therapy will be addressed in a special format with invited short talks and discussion sessions.
When submitting an abstract, please indicate the topic best covering your research. These are the seven main topics:
1. Genes, genetic defects and dependencies driving neuroblastoma.
This topic covers all new findings of genes and genetic defects implicated in neuroblastoma pathogenesis
2. Developments in precision therapy.
This topic covers all fundamental, translational and clinical studies of targeted therapy
3. Genetic heterogeneity in relation to resistance and relapse.
This topic focusses on the contribution of genetic defects on relapse development and therapy resistance.
4. Phenotypic plasticity in normal development and disease progression.
This topic focusses on the contribution of phenotypic plasticity on development of relapse and therapy resistance.
5. Developments in immune therapy.
This topic covers all fundamental, translational and clinical studies of immune therapy
6. Clinical trials and relapse treatment.
This topic covers new data on clinical trials and relapse protocols
7. Novel diagnostics (liquid biopsies, theranostics and imaging).
This topic will cover all developments in liquid biopsies, theranostics, imaging and novel diagnostic methods
General abstract submission guidelines
- Abstracts can only be submitted online via the abstract submission form. Abstracts sent by post or email will not be accepted.
- All mandatory fields must be filled out.
- Please choose one of the topics listed below* that best categorizes your abstract. This is important for the reviewing process.
- The maximum length of the abstract is 500 words. Tables, charts and other graphics are permitted and must be in JPG or GIF format and of high resolution (max. 2 graphics per abstract).
- After the submission deadline it is not possible to make any changes.
- Please ensure correct spelling, grammar and scientific content, as abstracts will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proof reading will be done.
- Individuals may be the first author of more than one abstract.
- The presenting author of the abstract must be registered for the meeting.
- Preferably use the following headings in your abstract:
- Background / introduction
- Methods / materials
- Summary / conclusion